Effect of Myrtol standardized on mucus hypersecretion and clearance of Pseudomonas aeruginosa in a rat model of chronic obstructive pulmonary disease

Arzneimittel-Forschung/Drug Research

Volumn 61, Issue 12, 2011, Pages 685-692

  Cao, Lihua ^a,b   Chen, Yu ^a   Zhao, Yue ^a   Zhang, Hongyan ^a   Wang, Shengli ^a   Wang, Zhenshan ^b   Kang, Jian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Bacterial clearance; Chronic obstructive pulmonary disease; Mucus production; Myrtol standardized; Pseudomonas aeruginosa infection

Indexed keywords

CIGARETTE SMOKE; INTERLEUKIN 6; MUCIN 5AC; MYRTOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; BRONCHUS MUCOSA; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENVIRONMENTAL EXPOSURE; GOBLET CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INOCULATION; MALE; METAPLASIA; MUCUS SECRETION; NONHUMAN; OPTICAL DENSITY; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RAT;

EID: 84455172891     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300588     Document Type: Article

References (33)

1. Livraghi A, Randell SH. Cystic fibrosis and other respiratory diseases of impairedmucus clearance. Toxicol Pathol. 2007;35:116-29. (Pubitemid 46328419)
2. Rabe KF, Beghé B, Luppi F, Fabbri LM. Update in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:1222-32. (Pubitemid 46905748)
3. Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir. J 2004;23:932-46. (Pubitemid 38807371)
4. Calverley PMA. Reducing the frequency and severity of exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1:121-4.
5. Zheng JP, Kang J, Huang SG, Chen P, Yao WZ, Yang L, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomized placebo-controlled study. Lancet. 2008;371:2013-8. (Pubitemid 351799858)
6. Meister R, Wittig T, Beuscher N, de Mey C. Efficacy and tolerability of Myrtol standardized in long-term treatment of chronic bronchitis: a double-blind, placebo-controlled study. Arzneimittelforschung. 1999;49(4):351-8. (Pubitemid 29198115)
7. Behrbohm H, Kaschke O, Sydow K. Effect of the phytogenic secretolytic drug Gelomyrtol forte on mucociliary clearance of the maxillary sinus. Laryngo Rhino Otol. 1995;74(12):733-7. (Pubitemid 26009124)
8. Wittig T. Myrtol standardized - A Clinical Documentation. Ergebnisse Verlag; 2005; 1st ed.; 22-26.
9. Juergens UR, Engelen T, Racké K, Stöber M, Gillissen A, Vetter H. Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes. Pulm Pharmacol Ther. 2004;17(5):281-7. (Pubitemid 39345409)
10. Beuscher N, Kietzmann M, Bien E, Champeroux P. Interference of Myrtol standardized with inflammatory and allergic mediators. Arzneimittelforschung. 1998;48(1): 985-9. (Pubitemid 28496757)
11. Anbarasi K, Vani G, Balakrishna K, Devi CS. Creatine kinase isoenzyme patterns upon chronic exposure to cigarette smoke: protective effect of Bacoside A. Vascul Pharmacol. 2005;42(2):57-61. (Pubitemid 40250180)
12. Swords WE, Buscher BA, Ver Steeg Ii K, Preston A, Nichols WA, Weiser JN, et al. Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol. 2000;37(1):13-27.
13. Vernooy JH, Dentener MA, van Suylen RJ, Buurman WA, Wouters EF. Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol. 2002;26(1):152-9. (Pubitemid 34029832)
14. Francisco JS, Moraes HP, Dias EP. Evaluation of the Image-Pro Plus 4.5 software for automatic counting of labeled nuclei by PCNA immunohistochemistry. Braz Oral Res. 2004;18(2):100-4.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods. 2001;25:402-8. (Pubitemid 34164012)
16. Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M. Regulation of mucociliary clearance in health and disease. Eur Respir J. 1999;13:1177-88. (Pubitemid 29288948)
17. Szilasi M, Dolinay T, Nemes Z, Strausz J. Pathology of chronic obstructive pulmonary disease. Pathol Oncol Res. 2006;12:52-60.
18. Verra F, Escudier E, Lebargy F, Bernaudin JF, De Crémoux H, Bignon J. Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers. Am J Respir Crit Care Med. 1995;151(3):630-4.
19. Zuhdi Alimam M, Piazza FM, Selby DM, Letwin N, Huang L, Rose MC. Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am J Respir Cell Mol Biol. 2000;22(3):253-60. (Pubitemid 30343350)
20. Kodavanti UP, Jackson MC, Ledbetter AD, Starcher BC, Evansky PA, Harewood A, et al. The combination of elastase and sulfur dioxide exposure causes COPD-like lesions in the rat. Chest. 2000;117(5 Suppl 1):299S-302S. (Pubitemid 30327002)
21. Ha U, Lim JH, Jono H, Koga T, Srivastava A, Malley R, et al. A novel role for Ikappa B kinase (IKK) alpha and IKK beta in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae. J Immunol. 2007;178(3):1736-47. (Pubitemid 46154645)
22. Ozlü T, Cay M, Akbulut A, Yekeler H, Naziroglu M, Aksakal M. The facilitating effect of cigarette smoke on the colonization of instilled bacteria into the tracheal lumen in rats and the improving influence of supplementary vitamin E on this process. Respirology. 1999;4(3):245-8. (Pubitemid 29434468)
23. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2(5):372-7. (Pubitemid 37328760)
24. Wedzicha JA. Airway infection accelerates decline of lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(10):1757-8. (Pubitemid 33152304)
25. Niederman MS. Introduction: COPD-the role of infection. Chest. 1997;112:301S-302S.
26. Drannik AG, Pouladi MA, Robbins CS, Goncharova SI, Kianpour S, Stämpfli MR. Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection. Am J Respir Crit Care Med. 2004;170(11):1164-71. (Pubitemid 39577373)
27. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168(8):918-51. (Pubitemid 37267172)
28. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;347(7);465-71. (Pubitemid 34879333)
29. Groenewegen KH, Wouters EF. Bacterial infections in patients requiring admission for an acute exacerbation of COPD: a 1-year prospective study. Respir Med. 2003;97(7):770-7. (Pubitemid 36763889)
30. Ramphal R, Arora SK. Recognition of mucin components by Pseudomonas aeruginosa. Glycoconjugate J. 2001;18(9):709-13. (Pubitemid 35398675)
31. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 2006;86(1):245-78.
32. Busse PJ, Zhang TF, Srivastava K, Lin BP, Schofield B, Sealfon SC, Li XM. Chronic exposure to TNF-alpha increases airway mucus gene expression in vivo. J Allergy Clin Immunol. 2005;116(6):1256-63. (Pubitemid 41740932)
33. Baginski TK, Dabbagh K, Satjawatcharaphong C, Swinney DC. Cigarette smoke synergistically enhances respiratory mucin induction by proinflammatory stimuli. Am J Respir Cell Mol Biol. 2006;35(2):165-74. (Pubitemid 44175315)